SecBot SecBot

CLGN

CollPlant Biotechnologies Ltd
Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies· Inc. L3· CIK 0001631487 Healthcare & Medical Devices
$3.90 +0.15 (+4.00%)
Oct 27 4:00 PM ET · prev $3.75
Market cap
$10.6M
Nano cap
Next earnings
Nov 24
in 28 days
1 year
−83.1%
from $23.10 · Oct 28
30 days
+0.8%
from $3.87
52-week range
$2.73–23.10
−83% from high · low Jul 31
Avg volume 20D
43.5K
Oct 9 spike 182.3K
Short interest
52.7K
≈1.8% of shares · +24.9%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 1 mention this week
Filing reports
21
analyzed by SecBot
SecBot read BEARISH 15 reports · 90 days
Balance 4 bearish · 0 bullish · 3 mixed · 8 neutral oldest → newest, height = score
Avg score ·High conf. 8/15 ·Next Earnings date, Nov 24, 2026
Strongest BEARISH CollPlant Biotechnologies has entered into a securities purchase agreement to sell shares and warrants at…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q2 2026: 3 added (0 new), 0 trimmed or exited.

  • Short sellersBUILDING

    Short interest +24.9% to 52.7K shares. 1.0 days to cover, ≈1.8% of shares.

  • TrendRANGE

    7% above its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup call.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCDOUBLED61,500$21.5K
CITADEL ADVISORS LLCADD53,700$18.7K
UBS Group AGDOUBLED1,035$361.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Feb 2026
Recent actions
DateFirmActionRating
Feb 6, 2026D. Boral Capital
DOWNGRADE
DOWNGRADEHold
Nov 28, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Oct 20, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Sep 16, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Aug 21, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy
Aug 20, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 1 in posts · 0 in comments
Recent posts
r/pennystocks Neutral 5d ago
CLGN: From breast implants to deep tech lasers
1 upvotes · 5 comments
All social signals and their track records

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Sep 3, 2026
Abelis Bar Berta
VP Legal
AWARD201,141 sh
Sep 3, 2026
Rotem Eran
Deputy CEO and CFO
AWARD510,372 sh

Earnings setup

Estimates
Nov 24
reports in 28 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 24, 2026
Earnings date
CLGN Q3 2026 Earnings Scheduled — 2026-11-24
Recent
Oct 6, 2026
Press release
LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
CollPlant Advances its Photonic Computing Strategy Through LightSolver's Growing IP Portfolio REHOVOT, Israel, Oct. 6, 2026 /PRNewswire/…
Sep 30, 2026
Earnings
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Strategic Expansion into Photonic Computing via LightSolver Acquisition Diversifies Technology Portfolio Alongside Continued Innovations in…
Sep 21, 2026
Listing
Listing Status: CLGN — Normal (was Deficient)
CollPlant Biotechnologies Ltd. - Ordinary Shares | Nasdaq Financial Status Indicator D → N
Sep 10, 2026
Press release
CollPlant to Host LightSolver Investor Webinar on September 17, 2026
REHOVOT, Israel, Sept. 10, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd…
Sep 4, 2026
Trading halt
Halt Resumed: CLGN — trading resumed after T3 (News and Resumption Times)
Halted 2026-09-03T23:50:00.000Z | Resumed 2026-09-04T13:00:00.000Z

Short side

FINRA· Oct 15, 2026
52,732
shares short
+24.9%
vs prior settlement
1.0
days to cover
≈1.8%
of shares outstanding
Trading halts
Sep 3, 2026Resumption ScheduledResumed
Aug 31, 2026Volatility PauseResumed
Aug 31, 2026Volatility PauseResumed
Aug 31, 2026Volatility PauseResumed
Aug 31, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 27, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 19, 2026 SEC
Ruty Ben Shlomi filed a Form 3 initial statement of beneficial ownership with CollPlant Biotechnologies, reporting…
3 — Impact 2/10
Oct 15, 2026 SEC
CollPlant Biotechnologies has entered into a securities purchase agreement to sell shares and warrants at $3.74 per…
6-K — Impact 6/10
Oct 6, 2026 Other
LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
CollPlant Advances its Photonic Computing Strategy Through LightSolver's Growing IP Portfolio REHOVO
Sep 3, 2026 Insider
Abelis Bar Berta was granted 201,141 shares
VP Legal
Sep 3, 2026 Insider
Rotem Eran was granted 510,372 shares
Deputy CEO and CFO
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
61,500 shares ($21.5K)
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — ADD
53,700 shares ($18.7K)

SecBot reports

21 filings · 0 bullish · 9 bearish · 3 mixed · 9 neutral
All CLGN filing & press-release reports (21)